Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

AI Is Now Detecting Cancer Years Before Doctors Can — New 2026 Research Shows How Machine Learning Is Transforming Diagnosis

A 2026 Nature Cancer AI identified 18 cancer types with high accuracy from minimal slides. A Mayo Clinic AI detected pancreatic cancer up to 3 years before diagnosis — nearly doubling specialist rates.

Medical Daily

Alzheimer's Treatment Is Entering a New Era — Here Is Everything That Has Changed in 2026

Leqembi and Kisunla are slowing Alzheimer's decline by 27-35% in early-stage patients. The 2026 drug pipeline has 158 candidates in 192 trials. Prevention trials are beginning. Here's the full update.

Medical Daily

The FDA Finally Approved a New Sunscreen Ingredient. It Only Took Over 25 Years.

The FDA's burdensome regulatory process has throttled sunscreen innovation.

Reason

From analysis to the latest developments in health,
read the most diverse news in one place.

Finerenone Kidney Drug Shown to Protect Heart and Kidneys in Millions More Patients After Three Major 2026 Studies

Three major studies published in NEJM, JAMA, and The Lancet in June 2026 show finerenone protects kidneys and hearts in non-diabetic CKD patients, expanding its potential reach to millions.

Medical Daily

Pet food recall expands to 20 US states amid concerns over serious neurological symptoms

Product could have potentially low levels of Vitamin B1, which is essential for ‘neurologic function in both cats and dogs’

The Independent UK

Medicare Is About to Cover Weight-Loss Drugs for the First Time — Here's What the GLP-1 Bridge Program Means for Millions of Americans with Obesity

Medicare's GLP-1 Bridge launches July 1, 2026, offering eligible Part D enrollees Wegovy and Zepbound for $50/month — the first-ever Medicare coverage for obesity-specific GLP-1 drugs.

Medical Daily

FDA Approves Bemotrizinol: First New Sunscreen Ingredient in 25 Years to Hit U.S. Market in 2026

The FDA approved bemotrizinol on June 9, 2026 — the first new sunscreen ingredient in the U.S. in more than 25 years. It provides superior UVA protection already used worldwide.

Medical Daily

Read news from The Economist, FT, and more,
with one subscription

Two Breakthrough Treatments Are Changing the Outlook for Americans with Treatment-Resistant Depression

New 2026 clinical data on Caplyta and Spravato offer major new hope for the roughly 7 million Americans with treatment-resistant depression. Here's what the evidence now shows.

Medical Daily

Salmonella Outbreak Linked to Moringa Supplements Expands to 119 Cases Across 36 States — FDA Issues New Recall

The FDA has expanded a Salmonella recall linked to moringa dietary supplements. 119 people across 36 states have been sickened, with 32 hospitalizations.

Medical Daily

Listeria Outbreak Kills One, Hospitalizes Seven: Soft Ricotta and Requeson Cheese Recalled in New York, Virginia, Maryland

A Listeria outbreak linked to Clover Hill Dairy soft ricotta and requesón cheese has killed one person and hospitalized seven others across three states.

Medical Daily

Cheese recalled in US after being linked to listeria outbreak that has left one dead and multiple sick

The cheese was sold in three different states

The Independent UK

What is bemotrizinol? The sunscreen ingredient that was just approved by FDA

IN FULL

The Independent UK

New sunscreen ingredient approved in US for first time in 25 years

Bemotrizinol received authorization from European authorities in 1999 and was first submitted to the FDA for review as far back as 2005

The Independent UK

Amneal Pharmaceuticals Bets on Biosimilars, Patches to Power Next Growth Phase

Amneal Pharmaceuticals (NASDAQ:AMRX) Co-Founder, President and Co-Chief Executive Officer Chirag Patel said the company is entering a stronger growth phase, driven by momentum in its existing generics portfolio, a newly expanded biosimilars platform and specialty product launches. Speaking at a Gol

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

FDA OKs first new sunscreen ingredient in more than 25 years

Federal health regulators have signed off on the first new sunscreen ingredient for the U.S. market in more than 25 years

Marie Claire

The FDA Just Approved a New Sunscreen Filter, Bemotrizinol, the First In 27 Years

Your skin is rejoicing.

Medical Daily

FDA Warns New Yorkers: Hepatitis A Linked to Frozen Blood Clams Sold in New York State — Illnesses Span Months

The FDA issued a public alert about hepatitis A-linked blood clams distributed in New York. Cases traced to La Serranita frozen blood clams imported from Ecuador. First illness reported in July 2025.

Medical Daily

FDA Issues Listeria Warning for Soft Ricotta and Requeson Cheese Sold in Philadelphia and Northeast Markets — Do Not Eat Recalled Products

The FDA issued a Listeria outbreak advisory on June 4, 2026, linked to requeson/soft ricotta cheese by Clover Hill Dairy. Products distributed in the Northeast, including Philadelphia-area markets.

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily

Breakthrough Drug Finerenone Now Proven to Protect the Kidneys and Heart in Millions More Patients Than Doctors Thought — Houston's CKD Patients Stand to Benefit Most

Major June 2026 studies show finerenone slows kidney disease and cuts heart failure risk even in patients without diabetes — expanding its benefit to millions. Houston has one of the highest CKD rates in Texas.

MarketBeat

Caribou Biosciences Says CRISPR CAR-T Is Pivotal-Ready, CB-011 Data Nears

Caribou Biosciences (NASDAQ:CRBU) Chief Executive Officer Rachel Haurwitz said the company is advancing two CRISPR-enabled, off-the-shelf CAR T cell therapy programs, with its lymphoma candidate vispa-cel now “pivotal-ready” and its multiple myeloma program CB-011 continuing in Phase 1 development.

Bangkok Post

Unsanitary meat factory shut down, products sold nationwide

PATHUM THANI – A meat processing factory that sells about 30 tonnes of branded products nationwide each month was shut down after failing to meet sanitary standards on Tuesday.

MarketBeat

Corbus Pharmaceuticals Teases Cancer, Obesity Data as Key Clinical Readouts Near

Corbus Pharmaceuticals (NASDAQ:CRBP) Chief Executive Yuval Cohen outlined the company’s near-term clinical readout schedule and development plans for its two lead drug candidates during a Jefferies fireside chat hosted by biotech analyst Amin Makarem. Cohen said the Norwood, Massachusetts-based dru

The Guardian - UK

GSK makes biggest ever acquisition with $10.6bn for US cancer drug firm

Nuvalent’s late-stage lung cancer treatments zidesamtinib and neladalkib are expected to launch later this year

MarketBeat

Compass Therapeutics Eyes FDA Path After Tovecimig Trial Win

Compass Therapeutics (NASDAQ:CMPX) Chief Executive Officer Tom Schuetz said the company is preparing for a key U.S. Food and Drug Administration meeting on tovecimig, its DLL4/VEGF bispecific antibody, after a randomized study in advanced biliary tract cancer met its primary endpoint and a key secon

Bangkok Post

Click with caution

According to the Technology Crime Suppression Division, the Central Investigation Bureau (CIB), there were over 50,000 cases of online shopping fraud from January to March, including delivery of products that did not match their advertisement and non-delivery even though payment had been made. The total damage exceeded 600 million baht.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.